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A B S T R A C T
Background: Organohalogen compounds (OHCs), i.e. polychlorinated biphenyls (PCBs, are wide-spread en-
vironmental pollutants known to be neurotoxic for the developing brain. The hydroxylated metabolites of PCBs,
OH-PCBs, might be even more toxic due to their structure and interference with thyroid hormone metabolism.
We found that prenatal exposure to OH-PCBs was associated with thyroid hormone metabolism at toddler age.
Little, however, is known about the neurotoxicity of OH-PCBs in humans.
Objectives: To determine whether prenatal background exposure to OHCs has an eﬀect on mental and motor
development in children at the age of 18 and 30 months.
Methods: One hundred and eighty-one healthy mother-infant pairs were included in this observational study
performed in the Netherlands. We measured maternal pregnancy levels of PCB-153 and three OH-PCBs. In one
part of the cohort we measured another nine PCBs and three OH-PCBs and in the other part we measured ﬁve
brominated diphenyl ethers (BDEs), dichloro-diphenyldichloroethylene (p,p’-DDE), pentachlorophenol (PCP),
and hexabromocyclododecane (HBCDD). We used the mental development index (MDI) and the motor devel-
opment index (PDI) of the Bayley Scales of Infant Development II (BSID-II) to assess children’s mental and motor
development (mean=100; delayed score< 85).
Results: Higher prenatal PCB-153 levels were associated with a delayed MDI score at 18 months. None of the
other compounds were associated with a delayed score, but several associations were found between OHC levels
and BSID-II scores. The sum of all six OH-PCBs and three individual OH-PCBs, 4-OH-PCB-107, 3-OH-PCB-153,
and 4′−OH-PCB-172, correlated positively with MDI at 30 months. The compound 3′−OH-PCB-138 showed a
similar trend. A higher 4-OH-PCB-187 was associated with a lower MDI at 18 months. We found a similar trend
for higher BDE-99. Higher BDE levels were associated with higher PDI at 18 months. The levels of p,p’-DDE-,
PCP, and HBCDD were not associated with BSID-II scores at 18 months.
Conclusions: Higher prenatal levels of PCB-153 were associated with a delayed MDI score at 18 months. None of
the other compounds were associated with a delayed score, but several associations were found between OHC
levels and BSID-II scores. Prenatal OH-PCBs were positively associated with mental development at 30 months,
whereas one OH-PCB was negatively associated at 18 months. BDE levels were positively associated with psy-
chomotor development. Prenatal p,p’-DDE, PCP, and HBCDD levels were not associated with neurodevelopment
at 18 months.
1. Introduction
Polychlorinated biphenyls (PCBs) are organohalogen compounds
(OHCs). These chemical compounds were widely used in industry as
ﬁre retardants, hydraulic liquids, and lubricants, to name but a few
applications. Although these compounds have been banned by law,
their properties cause them to break down slowly and therefore they
persist in the environment (McKinney and Waller, 1994). This raises
concerns as studies have shown that PCBs have adverse eﬀects, in-
cluding neurotoxicity and endocrine disruption. Animal studies showed
that endocrine disruption mainly involves the reproductive and thyroid
systems. Developing organisms seem to be the most vulnerable (León-
Olea et al., 2014).
Although to date several studies have been performed on the eﬀects
of exposure to PCBs on mental development in children, the outcomes
are not consistent. Some studies reported negative associations,
https://doi.org/10.1016/j.neuro.2019.01.003
Received 24 September 2018; Received in revised form 5 January 2019; Accepted 16 January 2019
⁎ Corresponding author at: Hanzeplein 1, PO Box 30.001, 9713 GZ, Groningen, the Netherlands.
E-mail address: s.a.berghuis@umcg.nl (S.A. Berghuis).
Neurotoxicology 72 (2019) 6–14
Available online 18 January 2019
0161-813X/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
whereas others reported positive associations or none at all (reviewed
by El Majidi and colleagues (El Majidi et al., 2013)). PCBs seem to have
a greater eﬀect on motor development than on mental development
(Rogan and Gladen, 1991; Koopman-Esseboom et al., 1996; Daniels
et al., 2003; Gladen et al., 1988; Walkowiak et al., 2001). In the present
cohort, we found an association between several PCBs and impairment
of early motor development in three-month-old children by assessing
their movement repertoire (Berghuis et al., 2013).
Under stimulation of the P450 enzyme complex in the liver, PCBs
can be converted into hydroxylated polychlorinated biphenyls (OH-
PCBs). OH-PCBs are water soluble and have shown to pass the placental
barrier in a higher ratio compared to PCBs (Soechitram et al., 2004). In
vitro and animal studies showed that OH-PCBs interfere with thyroid
hormone activity, an essential hormone for normal brain development
(Schuur et al., 1998; Kitamura et al., 2005). In our study on thyroid
hormone levels at toddler age we found more eﬀects of prenatal ex-
posure to OH-PCBs than to PCBs (Soechitram et al., 2017). These
ﬁndings suggest that OH-PCBs might be more toxic than PCBs, but only
a few studies are currently available on the eﬀects of OH-PCBs in hu-
mans. In our cohort higher prenatal exposure to 4-OH-PCB-107 was
associated with less than optimal early motor development in three-
month-old children, whereas 4′-OH-PCB-172 showed the opposite eﬀect
(Berghuis et al., 2013). Park and colleagues studied the eﬀects of six
OH-PCBs on neurodevelopment at 16 months and found 4-OH-PCB-107
to be negatively associated with mental and motor development (Park
et al., 2009).
Other OHCs were also found to be associated with poorer mental
and motor development (reviewed by Berghuis and colleagues
(Berghuis et al., 2015)). Higher prenatal exposure to brominated di-
phenyl ethers (PBDEs) was associated with poorer mental and psy-
chomotor development and lower IQs at preschool age. In our cohort,
prenatal exposure to PBDE levels correlated with poorer attention,
poorer ﬁne manipulative abilities, better coordination, better behavior,
and better visual perception in children at school age (Roze et al.,
2009). Regarding prenatal exposure to dichlorodiphenyldi-
chloroethylene (DDE), a breakdown product of the insecticide di-
chlorodiphenyltrichloroethane (DDT), some studies reported inverse
associations between exposure to DDE and neurodevelopmental out-
come, while others found no associations. Exposure to DDE seems to
interfere more with psychomotor development than with mental de-
velopment (Berghuis et al., 2015).
A reliable and widely used instrument to assess the mental and
motor development in children for both clinical and research purposes,
is the Bayley Scales of Infant Development (BSID) (Van der Meulen
et al., 2002; Bell and Allen, 2000).
Evidence on the negative health eﬀects of prenatal exposure to PCBs
is growing, but limited knowledge exists about the eﬀects of prenatal
exposure to OH-PCBs, PBDEs, and DDE (Berghuis et al., 2015). On ac-
count of the fact that in the Netherlands prenatal background PCB le-
vels are estimated to be three times higher than in the USA and that, as
a consequence, OH-PCB levels might also be higher, there is every
reason to investigate whether Dutch background exposure exerts ne-
gative health eﬀects (Longnecker et al., 2003). The present study was
conducted because to date the possible relationship between prenatal
Dutch OH-PCB levels and neurodevelopment at 18 and 30 months has
not been assessed. Because we assessed development at a young age,
thus minimizing the eﬀects of postnatal exposure, the ﬁndings of this
study contribute towards knowledge of the impact of prenatal back-
ground chemical exposure on early development.
The aim of this study was to determine whether prenatal back-
ground exposure to PCBs, OH-PCBs, and other OHCs is associated with
the mental and motor development of children at the age of 18 and 30
months in the Netherlands. We hypothesize that exposure to higher
levels of PCBs, OH-PCBs, and other OHCs have a negative eﬀect on the
mental and motor development of children.
2. Materials and methods
2.1. Cohort
For this observational longitudinal cohort study we included two
cohorts from the northern part of the Netherlands. The ﬁrst group of the
study population stems from the Risk of Endocrine Contaminants on
human health (RENCO) study (Soechitram et al., 2004). Pregnant
women were approached by their midwife or obstetrician to participate
in a study on the potential eﬀects of PCB and OH-PCB exposure on the
development of the child between September 1998 and December
2000. The second group stems from the Groningen Infant COMPARE
(Comparison of Exposure-Eﬀect Pathways to Improve the Assessment of
Human Health Risks of Complex Environmental Mixtures of Organo-
halogens) study, known as the GIC study (Meijer et al., 2008). This
study was launched as part of the European COMPARE study. These
women were invited by their midwives between October 2001 and
November 2002. Both cohorts only included women of western origin
who spoke Dutch as their native language. We excluded women who
experienced serious illnesses and/or complications during pregnancy
and/or delivery. Further, only full-term children, born between 37 and
42 weeks of gestation, were included. We excluded children with con-
genital anomalies or diseases and if they had been admitted to a hos-
pital for more than one day after birth. All parents gave their informed
consent. The study was approved by medical ethics committee of the
University of Groningen.
2.2. Chemical analysis
In both cohorts a blood sample was taken in the 35th week of
pregnancy to determine organohalogens levels in the blood (Soechitram
et al., 2004; Meijer et al., 2008). To determine the concentrations of
PCBs and OH-PCBs the blood was collected in a vacuum system tube
(EDTA) and centrifuged for ten minutes at 3600 rpm (RENCO cohort) or
for ﬁve minutes at 4000 rpm (GIC cohort). Subsequently, the plasma
was collected in separate glass tubes. These tubes were closed with a
screw cap with Teﬂon inlayers and stored at −18 C° to −20 C° until
analysis. Both studies used Hovander’s clean-up and extraction proce-
dure as is described by Hovander and colleagues (Hovander et al.,
2000). A detailed description of the analyses of the OHCs can be found
elsewhere (Soechitram et al., 2004; Meijer et al., 2008).
In the RENCO cohort ten PCBs and six OH-PCBs were measured to
determine the eﬀect of organohalogens on the development of children.
We also calculated the values for the sum of all ten PCBs and all six OH-
PCBs measured in the RENCO cohort, ΣPCBs and ΣOH-PCBs, respec-
tively. In addition, we calculated the sum of all dioxin-like mono-ortho-
substituted PCBs (105; 118; 156) and the sum of the other PCBs (138;
146; 153; 170; 180; 183; 187). The chemical activated luciferase gene
expression (CALUX) essay was used to measure the total toxic equiva-
lent quotient (TEQ) levels in maternal serum in the RENCO cohort.
CALUX can be used to detect certain planar halogenated aromatic hy-
drocarbons including PCBs. After the compounds bind to the aryl hy-
drocarbon receptor (AhR), the PHAH-AhR complex is transported into
the nucleus of the cell and subsequent binding to speciﬁc sequences in
the DNA (BioDetection Systems) occurs. In the GIC cohort we measured
PCB-153 and three hydroxylated PCB metabolites. We also measured
the following organohalogen compounds in the GIC cohort: p,p'-di-
chlorodiphenyldichloroethylene (p,p’-DDE), pentachlorophenol (PCP),
ﬁve diﬀerent brominated diphenyl ethers (BDEs) and hex-
abromocyclododecane (HBCDD). In Table 2 we show the maternal
pregnancy serum levels of the OHC compounds we measured. The PCBs
are numbered in accordance with Ballschmiter and colleagues and the
OH-PCBs according to Letcher and colleagues (Ballschmiter et al., 1993;
Letcher et al., 2000).
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2.3. Assessment of neurodevelopment
To determine the children’s neurodevelopment we used the Dutch
version of the second edition of Bayley Scales of Infant Development
(BSID-II-NL) at 18 months (both cohorts) and 30 months (RENCO co-
hort). This is a standardized test designed to assess the development of
children aged between 1 and 42 months in the Netherlands. It assesses
both mental and motor development and is widely used for both clinical
and research purposes (Bell and Allen, 2000). The tests were conducted
by trained examiners who were unaware of the child’s organohalogen
exposure levels. The BSID-II provides scores on the mental and motor
development of the child. Mental development is expressed in the
mental development index (MDI) and consists of 178 items. The mental
scale assesses the age-appropriate level of cognitive functioning, per-
sonal and social development, and language development. Motor de-
velopment is expressed in the psychomotor development index (PDI)
and consists of 111 items. The motor scale assesses ﬁne and gross motor
skills. The test provides raw scores for mental and motor development
that can be converted into standardized index scores of MDI and PDI,
based on norms for the Dutch population. These index scores have a
mean of 100, and a standard deviation of 15. A child with a test score
below 85 is considered to have a mildly delayed development; a score
below 70 indicates severe delay.
2.4. Statistics
To investigate whether prenatal exposure to OHCs is associated with
neurodevelopment at 18 or 30 months of age, we used the Spearman
partial correlation test to assess correlations between OHC levels and
MDI and PDI scores at 18 and 30 months corrected age. To determine
potential confounders we used the Spearman rank correlation and
Mann Whitney tests. We considered sex, birth weight, maternal
smoking during pregnancy, maternal alcohol use during pregnancy,
parity, and maternal education as potential confounders. We entered
these variables into the model if there was an association between OHC
levels and these variables with P< .15.
Next, we performed univariate logistic regression analyses for
compounds that correlated with BSID-II scores using the Spearman
partial correlation test to calculate odds ratios (ORs) for obtaining a
delayed MDI or PDI (< 85). We adjusted the results using multiple
logistic regression analyses, entering confounders with P < .15 into
the model. The tests were two-sided. We considered a P value of less
than .05 to be statistically signiﬁcant. A P value less than .10, but more
than .05 is mentioned as a trend, as is usual for toxicological studies.
We used the Statistical Package for the Social Sciences (SPSS), Version
23.0 for all the statistical analyses.
3. Results
3.1. Study group
The study group initially consisted of 194 mother-infants pairs (MI
pairs). Initially, 104 MI pairs were included in the RENCO cohort and
90 MI pairs in the GIC cohort (Soechitram et al., 2004; Meijer et al.,
2008). Four of the mother-infant pairs had to be excluded from the
RENCO cohort because no OHC levels were obtained. Another nine MI
pairs were excluded from the study because no BSID-II scores were
available at 18 months. In total, 181 (95.3%) of the 190 MI pairs par-
ticipated at the age of 18 months. At follow-up at 30 months of age, 63
(67.0%) of the 94 invited MI pairs of the RENCO cohort participated for
assessment of BSID-II scores. Table 1 shows the characteristics of the
study group. In the RENCO cohort a greater proportion of the mothers
smoked, 23% versus 9% in the GIC cohort. Frequently, the level of
education of mothers included in the GIC cohort was higher than that of
the mothers of in the RENCO cohort (56% and 47%, respectively).
3.2. OHC levels
In Table 2 we present the levels of OHCs measured in maternal
serum during pregnancy. PCB-153 had the highest mean concentration
of the PCBs (83 ng/g lipid weight) and 4-OH-PCB-187 had the highest
mean concentration of the OH-PCBs (87 ng/g fresh weight). As reported
previously, the CALUX results correlated positively with the individual
dioxin-like PCBs and the sum of the measured dioxin-like PCBs
(Soechitram et al., 2017).
3.3. Bayley scales of infant development
The BSID-II scores of the children at 18 and 30 months were cor-
rected for age and are presented in Table 1. The mean scores for MDI
and PDI in the 181 children included at 18 months were 97.1 and 90.1,
respectively. At 18 months, 13% of the children had a delayed score
(< 85) on MDI and 31% on PDI. For the 63 children included at 30
months of age, the mean MDI and PDI scores were 98.5 and 94.2. At 30
months, 11% of the children had a delayed score (< 85) on MDI and
18% on PDI. There were no diﬀerences between children who switched
from delayed to normal scores on PDI between 18 and 30 months
(n= 14) and the children with a delayed score on PDI at both time
points (n=8) regarding maternal education level (MWU=51.0, P=
.673) and parity (MWU= 53.0, P= .810).
3.3.1. Prenatal OHCs exposure to OHCs and neurodevelopment
In Table 3 we present the Spearman partial correlation coeﬃcients
of the relations between prenatal exposure to OHCs and BSID scores at
18 and 30 months corrected age. Higher maternal education was in-
cluded in all models because it was associated with higher MDI and PDI
scores at both time points (18 months: MWU=3391.0, P= .046;
MWU= 3274.0, P= .019; and 30 months: MWU= 369.0, P= .094,
MWU= 329.0, P= .041, respectively). Parity was associated with MDI
at both time points, with a higher rank for ﬁrst-born children (MWU=
2778.5, P= .005 and MWU= 309.0, P= .024). Maternal alcohol use
during pregnancy was associated with higher PDI at 30 months
(MWU= 289.5, P= .141). Finally, we dichotomized the scores into
normal and delayed scores and calculated the ORs for obtaining a de-
layed score. In Table 4 we present the ORs for the compounds that
correlated signiﬁcantly or showed a trend with BSID scores using the
Spearman partial correlation test (Tables 3 and 4).
3.3.2. Prenatal exposure to PCBs and neurodevelopment
Higher exposure to PCB-153 was associated with delayed MDI
scores at 18 months in the GIC cohort, but not in the combined cohort
(Table 4). None of the other PCBs were associated with a delayed score.
We did not ﬁnd any associations between exposure to PCBs and MDI
scores at 30 months or with PDI -scores at 18 or 30 months. The sum of
the mono-ortho-substituted dioxin-like PCBs, the sum of the other
measured PCBs, nor the CALUX-TEQ values were associated with BSID-
II scores.
3.3.3. Prenatal exposure to OH-PCB
Regarding OH-PCB exposure and mental development we found
both positive and negative associations (Table 3). At 18 months higher
exposure to 4-OH-PCB-187 in the GIC cohort correlated with a lower
MDI score. At 30 months of age higher exposure to four individual OH-
PCBs and the ΣOH-PCBs correlated with a higher MDI in the RENCO
cohort and a trend was seen for one OH-PCB (Table 3). After dichot-
omizing the scores into normal and delayed scores and correcting for
confounders, none of the OH-PCBs were either positively or negatively
associated with a delayed score (Table 4).
3.3.4. Prenatal exposure to other OHCs and neurodevelopment
Regarding exposure to the other measured OHCs and mental de-
velopment we found a trend between higher exposure to BDE-99 and
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lower MDI scores at 18 months (Table 3). Regarding psychomotor de-
velopment we found a positive correlation between exposure to BDE-
100 and PDI scores at 18 months, a similar trend was seen with ex-
posure to BDE-47 (Table 3). After dichotomizing the scores into normal
and delayed scores and correcting for confounders, none of the other
OHCs were either positively or negatively associated with a delayed
score (Table 4).
4. Discussion
In the present study, which was performed in the Netherlands, we
found that higher prenatal background exposure to several OHCs was
associated with mental and/or motor development at 18 or 30 months
of age. We found both positive and negative associations. Our most
important ﬁnding was that OH-PCBs were positively associated with
mental development at 30 months. PCB-153, BDE-99, and 4-OH-PCB-
187 were negatively associated with mental development at 18 months.
Two PBDEs were positively associated with motor development at 18
months.
4.1. Prenatal exposure to OH-PCBs and neurodevelopment
Our most important ﬁnding was that prenatal exposure to OH-PCBs
was associated with more optimal mental development at 30 months of
age. We found a positive association between the sum of all OH-PCBs
and four individual OH-PCBs (4-OH-PCB-107, 3′-OH-PCB-138, 3-OH-
PCB-153, 4′-OH-PCB-172) and mental development at 30 months. The
ﬁnding that 4′-OH-PCB-172 was positively associated with develop-
ment at 30 months is consistent with our previous ﬁnding that the
compound was positively associated with neurodevelopment at three
months of age (Berghuis et al., 2013). The compound 4-OH-PCB-107 is
a metabolite of PCB-105 and PCB-118, both of which are dioxin-like
PCBs. Enhanced neurodevelopment was found after higher prenatal
exposure to dioxin-like PCBs in our cohort at the age of three months
(Berghuis et al., 2014) and also after higher perinatal dioxin exposure in
another Dutch cohort of children at the age of two years and seven
months (Ilsen et al., 1996). A possible explanation for such enhanced
development could be agonistic eﬀects on thyroid hormone functions.
In our cohort we found higher levels of T4 and T4 sulfate at three and
18 months after higher prenatal OH-PCB exposure (Soechitram et al.,
2017) and in Ilsen and colleagues’ cohort a relatively high thyroid
function during the ﬁrst 11 weeks after birth was observed in children
with high perinatal dioxin exposure (Pluim et al., 1993).
In contrast to previous studies and to ﬁndings in our cohort at the
age of three months, we did not ﬁnd negative eﬀects of the metabolite
4-OH-PCB-107 on motor development. An animal study in rats in-
dicated that exposure to 4-OH-PCB-107 had a long-term eﬀect on de-
velopment and behavior (Meerts et al., 2004). In the children included
in the RENCO cohort, background exposure to 4-OH-PCB-107 was as-
sociated with impairment of motor development at the age of three
months (Berghuis et al., 2013) and a negative association between 4-
OH-PCB-107 and neurological function was found in boys at three
months of age (Berghuis et al., 2014). A Slovakian study found a ne-
gative association between prenatal exposure to 4-OH-PCB-107 and
motor development in 16-month-old children who were assessed by
using BSID-II (Park et al., 2009). A possible explanation for the fact that
we did not ﬁnd similar associations with 4-OH-PCB-107 levels might be
diﬀerences in OH-PCB levels. We found higher 4-OH-PCB-107 levels
than Park and colleagues: 52 versus 37 pg/g wet weight (Park et al.,
2009). Unlike the 4-OH-PCB-107 levels, we found lower levels of the
other OH-PCB congeners in comparison to the Slovakian study: for 4-
OH-PCB-146 99 versus 147 pg/g fresh weight and for 4-OH-PCB-187
117 versus 273 pg/g fresh weight. However, the mean PDI found by
Park and colleagues was much higher than in our study: 99.8 versus
90.1. Another diﬀerence between our study and the Slovakian study is
that we used the BSID-II version, which is standardized for the Dutch
population, whereas they did not use a version that had been standar-
dized for their population. Instead, they used a modiﬁcation of the
American version. This might also contribute to the explanation for the
diﬀerences in the ﬁndings between the two populations. The Slovakian
study also investigated other OH-PCB congeners, but these congeners
show no signiﬁcant associations with mental or motor development at
16 months of age (Park et al., 2009). This is partly in line with our
result of ﬁnding only one OH-PCB congener to be associated with
Table 1
Characteristics of the study group.
18 months 30 months







Gender (male/female) 105/76 (58%) 50/44 (53%) 55/32 (63%) 36/27 (57%)
Gestational age (weeks, mean ± SD) 40 ± 1 40 ± 1 40 ± 1 40 ± 1
Apgar score 1min [median (range)] 9 (2-10) 9 (2-10) 9 (3-10) (6-10)
Apgar score 3min [median (range)] 10 (6-10) 10 (6-10) 10 (7-10) (6-10)
Age at examination (months; mean ± SD) 18 ± 0.5 18 ± 0.5 18 ± 0.5 30 ± 0.5
Mother
Maternal age (years; mean ± SD) 32 ± 4 32 ± 4 32 ± 4 32 ± 4
Maternal smoking, yes/no (%) 30/150 (17%) 22/72 (23%) 8/78 (9%) 19/44 (30%)
Maternal alcohol consumption, yes/no (%) 46/134 (25%) 23/71 (24%) 23/63 (26%) 18/45 (29%)
Parity, ﬁrst-born/second-, or third-born (%) 63/118 (35%) 34/60 (36%) 29/58 (33%) 24/39 (38%)
Maternal education level (%)
Below average (≤ 11 years of education) 16 (9%) 12 (13%) 4 (5%) 8 (13%)
Average (12-13 years of education) 72 (40%) 38 (40%) 34 (39%) 27 (43%)
Above average (≥ 14 years of education) 93 (51%) 44 (47%) 49 (56%) 28 (44%)
MDI
Mean ± SD 97.1 ± 13.3 97.6 ± 13.8 96.7 ± 12.7 98.5 ± 10.7
Normal (≥ 85) 157 (87%) 84 (89%) 73 (84%) 56 (89%)
Mildly delayed (70-85) 21 (12%) 8 (9%) 13 (15%) 7 (11%)
Severely delayed (< 70) 3 (2%) 2 (2%) 1 (1%) 0 (0%)
PDI
Mean ± SD 90.1 ± 10.2 89.3 ± 10.5 91.1 ± 9.9 94.2 ± 15.1
Normal (≥ 85) 124 (69%) 61 (65%) 63 (72%) 51 (82%)
Mildly delayed (70-85) 51 (28%) 29 (31%) 22 (25%) 7 (11%)
Severely delayed (< 70) 6 (3%) 4 (4%) 2 (2%) 4 (6%)
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mental development at the age of 18 months. We mainly found asso-
ciations between prenatal OH-PCB levels and mental development at 30
months of age, whereas these OH-PCBs were not found to be associated
with development at the age of 18 months. A possible explanation for
the fact that we did not observe eﬀects at 18 months of age could be
that the eﬀects might appear more subtle at younger ages and might
therefore not result in signiﬁcant changes in MDI scores. Another ex-
planation for the positive and earlier negative eﬀects might be that the
tests were performed during toddler age, an age during which major
transformation of neural functions take place and the quality rather
than the quantity of the motor repertoire changes (Hempel, 1993). We
speculate that in later life the eﬀects of prenatal exposure on develop-
mental outcomes might become more apparent. At the age of 30 months
we found a positive association between MDI scores and the sum of the
OH-PCBs and four separate OH-PCBs. However, after subdividing the
group into children with normal and delayed MDI, we did not ﬁnd
signiﬁcant diﬀerences with regard to prenatal OH-PCB levels. This
might suggest a more general eﬀect of exposure positively aﬀecting the
mental development without resulting in a lower risk of obtaining a
delayed score.
4.2. Prenatal exposure to PCBs and neurodevelopment
We found higher exposure to PCB-153 to be associated with a higher
risk of obtaining a delayed MDI score (< 85) at 18 months. Other
studies on the eﬀects of PCBs showed diﬀerent outcomes for mental
than for motor development, as reviewed by El Majidi and colleagues
and by Faroon and colleagues (El Majidi et al., 2013; Faroon et al.,
2000). The results of the previous studies point to a relation between
prenatal exposure to PCBs and a less than optimal performance on
motor skills during ﬁrst months of life. Later eﬀects seem to involve
mainly cognitive areas (Ribas-Fito et al., 2001). Exposure to PCB-153,
in particular, is often found to be associated with developmental out-
comes in children (Casas et al., 2015; Gascon et al., 2013; Verner et al.,
2010). PCB-153 is the most abundant congener in humans. This could
be an explanation for ﬁnding an eﬀect of PCB-153 only. An animal
study found that PCB-153 aﬀects the regulation of the intracellular
signaling systems in the brain (Bemis and Seegal, 2004). Moreover,
PCB-153 alters neurotransmitter functions in rats, causing a decrease in
brain serotonin and dopamine that are essential for the proper devel-
opment of the brain (Castoldi et al., 2006).
4.3. Prenatal exposure to PBDE and neurodevelopment
We found a negative trend between prenatal levels of BDE-99 and
mental development at 18 months. Regarding motor development BDE-
100 and BDE-47 showed a positive trend with outcomes at 18 months.
Regarding exposure to PBDEs most studies demonstrated strong inverse
eﬀects on mental development. Inconsistent eﬀects were found for
motor development (reviewed by Roth and Wilks (Roth and Wilks,
2014)). Animal studies seem to conﬁrm the impact on mental devel-
opment. They revealed that exposure to PBDEs can alter spontaneous
behavior resulting in increased impulsivity, hyperactivity, and dis-
rupted habituation. Moreover, attention, learning, and memory func-
tions were impaired (reviewed by Dingemans and colleagues
(Dingemans et al., 2011)). In our cohort prenatal exposure to PBDE
levels was correlated with poorer attention, poorer ﬁne manipulative
abilities, better coordination, better behavior, and better visual per-
ception in children at school age (Roze et al., 2009). It might well be
that eﬀects of prenatal exposure to PBDEs become more apparent at a
later age. More studies are needed on the potential eﬀects of prenatal
exposure to PBDEs on psychomotor development.
4.4. Prenatal exposure to DDE, PCP, and HBCDD and neurodevelopment
We did not ﬁnd associations between prenatal exposure to p,p’-DDE,
PCP, or HBCDD and mental or motor development at 18 months of age.
Several studies on the eﬀects of p,p’-DDE showed impairment of mental
and motor development in children aged between three and 24 months
(reviewed by Eskenazi and colleagues (Eskenazi et al., 2009)). In later
life, studies predominantly reported no associations between exposure
to p,p’-DDE and neurodevelopment. A possible explanation for the fact
that we found no associations might be that the levels measured in our
study were too low to exert eﬀects in the children.
4.5. Mechanisms of neurotoxicity
A possible explanation for the neurotoxicity of OHCs might involve
the interactions of OHCs with the endocrine system, particularly the
thyroid hormone system (Brouwer et al., 1998). The thyroid hormone
system is hugely important for the normal maturation of the brain. It
inﬂuences neuronal proliferation and migration in the brain, as well as
synapse formation (Williams, 2008). The thyroid hormone system is
also essential for timing these processes. Studies in animals and humans
showed that OHC exposure can lead to disturbances of the thyroid
hormone system (for review see Brouwer and colleagues (Brouwer
et al., 1998)) (Soechitram et al., 2017; Koopman-Esseboom et al.,
1994). Disruption of the endocrine system can be the result of an
agonistic or antagonistic action of the chemicals. The structures of
several OHCs are highly similar to the chemical structures of thyroid
Table 2
Organohalogen levels in maternal serum samples during pregnancy.
Compound Median (IQR) n
PCB-105a 4.2 (2.1–11.3) 94
PCB-118a 21.0 (14.6–33.9) 94
PCB-138a 68.7 (48.9–86.2) 94
PCB-146a 8.2 (5.0–13.7) 94
PCB-153 88.0 (68.8–144.0) 181
-RENCO 91.9 (63.2–123.2) 94
-GIC 62.9 (43.2–80.4) 87
PCB-156a 11.1 (7.8–14.7) 92
PCB-170a 19.0 (13.5–25.4) 92
PCB-180a 45.2 (31.7–58.5) 92
PCB-183a 8.2 (5.6–10.4) 94
PCB-187a 12.3 (8.6–17.8) 94
Σ dl-PCBsa,b 38.7 (24.1–60.8) 92
Σ non-dl-PCBsa,c 259.3 (181.4-334.3) 92
Σ 10 PCBsa 296.8 (217.5–391.1) 92
CALUX-TEQ 19.5 (13.8–60.4) 92
4-OH-PCB-107 42.0 (23.0–76.6) 175
-RENCO 69.0 (42.0–100.0) 91
-GIC 26.1 (17.8–38.6) 84
3’-OH-PCB-138a 46.0 (31.0–66.0) 91
4-OH-PCB-146 80.3 (61.0–128.4) 178
-RENCO 70.0 (53.0–100.0) 91
-GIC 102.4 (72.4–140.0) 87
3-OH-PCB-153a 38.0 (24.0–54.0) 91
4’-OH-PCB-172a 16.0 (10.0–22.0) 72
4-OH-PCB-187 105.0 (78.6–148.0) 178
-RENCO 136.0 (105.0–172.0) 91
-GIC 79.8 (59.3–100.6) 87
Σ 6 OH-PCBsa 388.5 (275.8–546.3) 72
p,p’-DDEd 88.0 (68.8–144.0) 87
PCPd 972.5 (686.3–1641.2) 87
BDE-47d 0.85 (0.53–1.30) 60
BDE-99d 0.20 (0.10–0.40) 57
BDE-100d 0.20 (0.10–0.30) 60
BDE-153d 1.55 (1.20–2.20) 60
BDE-154d 0.50 (0.40–0.78) 60
HBCDDd 0.82 (0.47–1.26) 59
PCBs, DDE, PCP, BDEs, and HBCDD in ng/g lipid weight; OH-PCBs in ng/g fresh
weight; CALUX levels in pg TEQ/g lipid.
a RENCO cohort.
b sum of dioxin-like PCBs (105; 118; 156).
c sum of non-dioxin-like PCBs (138; 146; 153; 170; 180; 183; 187).
d GIC cohort.
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hormones and therefore might interact with their receptors (McKinney
and Waller, 1994; McDonald, 2002). According to an animal study, OH-
PCBs exhibit agonistic thyroid hormone activity as a result of interac-
tion with thyroid hormone receptors (TR) (Kitamura et al., 2005). In-
teraction with these TRs disrupts normal thyroid homeostasis, poten-
tially resulting in abnormalities in brain development. The study
demonstrated that a 4-hydroxyl group and 3,5-chlorine substituent on
the phenyl group were required for this interaction with TR. This is a
possible explanation for our ﬁnding that OH-PCBs with a 4-hydroxyl
group were associated with neurodevelopment. And it is in accordance
with our earlier ﬁndings in which we describe associations between
prenatal OH-PCB exposure and thyroid hormone metabolism at three
and 18 months (Soechitram et al., 2017). Studies in animals and in vitro
studies showed that OHCs can bind to the transthyretin receptor (TTR),
a transport protein in the blood and cerebral ﬂuid for T4 (Lans et al.,
1994; Meerts et al., 2002). In vitro studies showed that both PCBs and
OH-PCBs were able to bind to TTR, although only the aﬃnity of OH-
PCBs to TTR was able to compete with T4 binding (Lans et al., 1994;
Meerts et al., 2002). A study in rats showed an aﬃnity of 4-OH-PCB-107
with the thyroid transport protein TTR (Meerts et al., 2004). Binding of
4-OH-PCB-107 to TTR could be a reason for lower circulating T4 levels
in animals, found in both fetal plasma and brains, as seen by Morse and
colleagues (Morse et al., 1996). The presence of OH-PCBs in the fetal
animal may result in a decrease in circulating plasma T4 levels and
brain T4 levels. A similar mechanism is seen for metabolites of PBDEs
(Brouwer et al., 1998). In humans, however, most T4 transport depends
on the thyroxin-binding globulin (TBG) (Brouwer et al., 1998). Never-
theless, binding of T4 to TTR might be important in humans for
transport across the blood-brain barrier. PCBs and OH-PCBs therefore
might inﬂuence brain levels of thyroid hormones in humans. In the
current study, we found most eﬀects to be associated with prenatal
exposure to OH-PCBs, which suggest OH-PCBs to be more toxic than
PCBs and other OHCs. This is similar to the ﬁndings in animal studies
and in our study on thyroid hormone levels at toddler age (Kitamura
et al., 2005; Soechitram et al., 2017; Kimura-Kuroda et al., 2007).
Table 3
Spearman’s partial correlation coeﬃcients of organohalogen compounds and Bayley Scale of Infant Development scores at age of 18 and 30 months.
18 months 30 months
MDI PDI MDI PDI
Compound n Rhoa P value Rhob P value n Rhoa P value n Rhoc P value
PCB-105d 94 .000 .998 .005 .961 63 −.105 .419 62 −.103 .434
PCB-118d 94 .072 .495 .044 .676 63 −.037 .780 62 −.147 .262
PCB-138d 94 .090 .395 .132 .209 63 .120 .358 62 .007 .959
PCB-146d 94 .020 .851 .037 .724 63 .043 .744 62 −.031 .816
PCB-153 181 −.025 .742 .016 .826
-RENCO 94 .077 .466 .111 .288 63 .077 .555 62 −.025 .850
-GIC 87 −.206 .059# −.040 .712 n.a. n.a.
PCB-156d 92 .060 .572 .111 .295 61 .111 .402 60 .026 .847
PCB-170d 92 .137 .199 .096 .364 61 .205 .119 60 .086 .522
PCB-180d 92 .118 .270 .084 .427 61 .198 .133 60 .084 .529
PCB-183d 94 .004 .972 .058 .581 63 −.050 .702 62 .038 .771
PCB-187d 94 .076 .471 .050 .633 63 .067 .610 62 .034 .799
Σ dl-PCBsd,e 92 .067 .532 .052 .622 61 −.006 .962 60 −.108 .420
Σ non-dl-PCBsd,f 92 .083 .436 .098 .353 61 .112 .398 60 −.029 .832
Σ 10 PCBsd 92 .075 .483 .097 .361 61 .101 .444 60 −.037 .781
CALUX-TEQd 92 .016 .884 -.083 .433 63 .035 .788 62 .169 .197
4-OH-PCB-107 175 .043 .573 .029 .705
-RENCO 91 .074 .492 .125 .239 61 .298 .022* 60 .151 .257
-GIC 84 −.101 .365 .065 .560 n.a. n.a.
3’-OH-PCB-138d 91 −.030 .777 .014 .893 61 .225 .086# 60 .106 .426
4-OH-PCB-146 178 −.105 .167 .045 .555
-RENCO 91 .015 .887 .107 .314 61 .201 .127 60 .098 .465
-GIC 87 −.178 .103 −.088 .418 n.a. n.a.
3-OH-PCB-153d 91 .069 .519 .006 .958 61 .295 .023* 60 .065 .630
4’-OH-PCB-172d 72 .089 .465 −.023 .847 48 .396 .006** 47 .218 .150
4-OH-PCB-187 178 −.113 .137 −.111 .140
-RENCO 91 −.020 .849 −.007 .946 61 .039 .768 60 −.081 .547
-GIC 87 −.253 .019* −.178 .100 n.a. n.a.
Σ 6 OH-PCBsd 72 .025 .835 −.063 .599 48 .367 .012* 47 .133 .383
p,p’-DDEg 87 −.058 .601 .076 .485 n.a. n.a.
PCPg 87 −.039 .725 .068 .532 n.a. n.a.
BDE-47g 60 −.193 .147 .237 .071# n.a. n.a.
BDE-99g 57 −.232 .089# .185 .172 n.a. n.a.
BDE-100g 60 −.096 .473 .273 .036* n.a. n.a.
BDE-153g 60 −.025 .854 .183 .165 n.a. n.a.
BDE-154g 60 −.136 .308 −.098 .460 n.a. n.a.
HBCDDg 59 −.133 .324 .004 .979 n.a. n.a.
a corrected for parity and maternal education level.
b corrected for maternal education level.
c corrected for maternal alcohol use during pregnancy and maternal education level.
d RENCO cohort.
e sum of dioxin-like PCBs (105; 118; 156).
f sum of non-dioxin-like PCBs (138; 146; 153; 170; 180; 183; 187).
g GIC cohort.
** P< .01.
* P< .05; # P< .10. Abbreviations: MDI - mental development index, PDI - psychomotor development index, n.a.- not assessed.
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4.6. Strengths and limitations
A strength of our study is the measurement of prenatal background
exposure of individual OHCs in healthy children, in which we also in-
vestigated the eﬀects of OH-PCBs. Only a few studies have been per-
formed on the impact of OH-PCBs on neurodevelopment. Although the
levels of OH-PCB are generally lower in comparison to other studies, we
did ﬁnd associations. This suggests that even lower levels seem to aﬀect
the child’s development. A second strength is that we assessed the de-
velopment in one part of the cohort at two diﬀerent ages. Although the
sample size is smaller for the analyses at 30 months of age, we were
able to obtain more insight into consistency between the outcomes at
18 and 30 months.
Our study also has limitations. The ﬁrst limitation we address is the
possibility of Type 1 errors due to the explorative nature of the study.
Nevertheless, we believe that our analyses were justiﬁed as part of a
careful evaluation of a rich data set in hypothesis-driven research
(Rothman, 1990). A second limitation is the relatively small sample
size. We only found signiﬁcant results in one of the two cohorts, but not
in the cohorts combined. This limits deﬁnite conclusion about whether
our ﬁndings, especially negative ones, are valid. In our opinion, these
sizes are appropriate for such complicated studies that involve, invol-
ving the assessment of multiple OHCs. Nevertheless, our results need to
be interpreted with caution. A third limitation is that we included
children from two cohorts. This might have led to diﬀerences in in-
clusion and characteristics of the two study groups. Although the GIC
cohort included higher educated women, other characteristics of the
two cohorts were comparable, for example demographics and methods
used. Because we noticed diﬀerences between the cohorts, we decided
to also report on the sub analyses for both cohorts separately for those
compounds which were measured in both cohorts. A fourth limitation is
that we found relatively low scores for both MDI and PDI at 18 months.
Meta-analyses already showed that ﬁndings of the BSID-II might un-
derestimate mental and motor development resulting, more frequently,
in lower scores (Santos et al., 2013). Another explanation for the re-
latively low scores could be the relatively young age at examination.
The children were seen at the age of 18 months. At this age, the range in
development is considerable as far as the achievement of various
milestones in both mental and motor development is concerned. Ad-
ditionally, rapid development is characteristic of this age, making it
diﬃcult to obtain a good impression of the development at that mo-
ment. Testing a few weeks later could result in essential diﬀerences in
scores if the child had obtained certain milestones in the meantime.
Moreover, especially the evaluation of the motor development depends
to a large extent on the children’s behavior and their willingness to
perform the tests, which requires experience of the examiner. Even so,
the BSID-II is a standardized test, administered by experienced ex-
aminers, and we kept close to 18 months as the age of assessment, re-
sulting in a SD for age of assessment of two weeks. Another limitation is
a potential selection bias due to voluntary participation of the women
to our study. The women who agreed to participate might be interested
in the eﬀects of environmental compounds and therefore might show
more awareness regarding their life style and eating habits. Such
awareness, however, does not mean that these women did indeed
change their habits. Perhaps they did not possess the means to do so, or
they lacked the knowledge on how to avoid exposure to these pollu-
tants. As regards inclusion, we did include many highly educated
women. This could have aﬀected the general development of the chil-
dren. Nevertheless, we did correct for the level of maternal education,
which had no signiﬁcant eﬀect on our outcome. A ﬁnal limitation is that
we cannot exclude the possibility that co-exposure to other OHCs
confounded our ﬁndings, because all children are exposed to a mixture
of chemicals. On account of these limitations the results of our study
should be considered as exploratory, and our results should be inter-
preted with caution.
4.7. Implications
Our ﬁndings suggest that prenatal background exposure to OHCs is
associated with the children’s neurodevelopment at toddler age. Less is
known about the eﬀects of prenatal exposure, of OH-PCBs in particular.
Our study seems to suggest that it has subtle eﬀects early in life.
Although the eﬀects might be subtle for the individual, it may still have
a great impact at population level. The eﬀects found could be tem-
porary or evolve over years. Behavioral problems seem to be increasing
in the population, with the exposure to environmental pollutants as a
potential explanation. Even though, some of the compounds were po-
sitively associated with mental development, chemical compounds are
not supposed to interfere with children’s development, and an en-
hanced development might possibly occur at the expense of the for-
mation of stable neural networks. Less is known about the long-term
eﬀects of prenatal exposure to OH-PCBs. Further research is required to
determine the consequences of prenatal exposure to OHCs later in life.
Further knowledge is also needed on the biological and biochemical
actions of these compounds to prevent the production of chemical
compounds with similar eﬀects.
Table 4
Odds ratios for associations between prenatal organohalogen compound levels and delayed mental or motor development at 18 and 30 months of age.
Compound Outcome Age in months OR (95% CI) P-value Adjusted OR (95% CI) P-value
PCB-153a,* MDI 18 1.02 (1.00-1.04) .030 1.02 (1.00–1.04)b .023
4-OH-PCB-107c,# MDI 30 0.98 (0.95-1.01) .110 0.98 (0.95–1.01)b .126
3’-OH-PCB-138c,# MDI 30 0.99 (0.96-1.02) .443 0.99 (0.97–1.02)b .459
3-OH-PCB-153c,# MDI 30 0.98 (0.94-1.02) .264 0.98 (0.94–1.02)b .283
4’-OH-PCB-172c,# MDI 30 0.87 (0.72-1.05) .153 0.87 (0.72–1.05)b .142
4-OH-PCB-187c,# MDI 18 1.39 (1.15-1.69) .001 1.01 (1.00–1.02)b .150
Σ 6 OH-PCBsc,# MDI 30 0.99 (0.99-1.00) .153 0.99 (0.99–1.00)b .166
BDE-47a,* PDI 18 0.80 (0.44-1.46) .464 0.79 (0.44–1.45)d .453
BDE-99a,** MDI 18 1.14 (0.98-1.33) .089 1.13 (0.97–1.33)b .127
BDE-100a,** PDI 18 0.88 (0.67-1.17) .379 0.88 (0.66–1.16)d .369
Associations are only shown for the compounds that were associated with a P< .10 in the Spearman partial analyses.
Abbreviations: OR - odds ratio, CI - conﬁdence interval, MDI - mental development index, PDI - psychomotor development index.
a GIC cohort.
b adjusted for parity and maternal education level.
c RENCO cohort.
d adjusted for maternal education level.
* per ng/g lipid weight.
** per 0.1 ng/g lipid weight.
# per pg/g fresh weight.
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5. Conclusions
In one cohort higher prenatal levels of PCB-153 were associated
with delayed MDI scores at 18 months. None of the other compounds
were associated with a delayed score, but several associations were
found between OHC levels and BSID-II scores. In our study, higher
prenatal background OH-PCB exposure in the Netherlands was asso-
ciated with neurodevelopment at 18 and 30 months of age, both ad-
versely and positively. Our data suggest that OH-PCBs exert more ef-
fects on mental development than on motor development, and that OH-
PCBs exert more eﬀects than PCBs. Four OH-PCBs and the sum of 6 OH-
PCBs were positively associated with mental development at 30
months, whereas one OH-PCB was negatively associated at 18 months.
Prenatal exposure to BDE-99 was negatively associated with mental
development at 18 months, BDE-47 and BDE-100 were positively as-
sociated with motor development. Prenatal p,p’-DDE-, PCP, or HBCDD
levels were not associated with mental or motor development at 18
months of age. Larger studies are needed to conﬁrm our data.
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